Uncover key drivers, emerging technologies, and competitive movements shaping the enzymes market from 2025–2034 with trusted insights from The Business Research Company
What Are The Market Size Estimates For The Enzymes Market Now And By 2029?
The market size for enzymes has experienced rapid expansion in recent years. It is anticipated to increase from $13.38 billion in 2024 to $15.2 billion in 2025, driven by a compound annual growth rate (CAGR) of 13.6%. The historical surge in this market can be ascribed to elements like globalization and market expansion, along with research and development investments, rising consumer awareness and demand, enhancements in bioprocessing technology, and initiatives for waste reduction and recycling.
The enzymes market is projected for swift expansion in the upcoming years, reaching a valuation of $25.34 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 13.6%. This anticipated growth during the forecast period is driven by various factors such as evolving market demand dynamics, an increased emphasis on sustainable practices, prevalent health and nutrition trends, the rise of biofuel and renewable energy sectors, and the development of new applications. Key developments anticipated in this period include advances in biotechnology, escalating demands for sustainability, increasing requirements from the food and beverage industry, broader industrial applications, and a growing consumer preference for natural products.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3425&type=smp
Which Long-Term Drivers Are Expected To Sustain The Enzymes Market?
The increasing occurrence of digestive ailments is anticipated to drive the expansion of the enzyme market in the future. These are medical conditions impacting the digestive system. Notable examples of such disorders comprise gastroesophageal reflux disease (GERD), cancer, irritable bowel syndrome (IBS), lactose intolerance, hiatal hernia, and gallstones. Enzymes for digestion aid in breaking down food into tinier molecules for bodily absorption. As an illustration, data from October 2022 by the National Center for Biotechnology Information (NCBI), a US-based scientific research resource, indicates that the prevalence of irritable bowel syndrome (IBS) varies from 10% to 15% in the United States, with approximately 12% of patients seeking medical attention in primary care settings for IBS-related issues. Consequently, the increasing incidence of digestive problems is fueling the expansion of the enzyme market.
How Is The Enzymes Market Classified By Different Segments?
The enzymes market covered in this report is segmented –
1) By Product Type: Asparaginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Other Products
2) By Application: Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease, Other Applications
3) By End User: Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories
Subsegments:
1) By Asparaginase: L-asparaginase, Erwinia Asparaginase, Pegylated Asparaginase
2) By Lipase: Gastric Lipase, Pancreatic Lipase, Fungal Lipase, Bacterial Lipase
3) By Protease: Serine Proteases, Cysteine Proteases, Aspartic Proteases, Metalloproteases
4) By Nattokinase: Nattokinase Powder, Nattokinase Capsules
5) By Chitinase: Plant Chitinase, Microbial Chitinase
6) By Serratiopeptidase: Serratiopeptidase Tablets, Serratiopeptidase Capsules
7) By Collagenase: Type I Collagenase, Type II Collagenase, Type III Collagenase
8) By Ligase: DNA Ligase, RNA Ligase
9) By Other Products: Amylase, Cellulase, Beta-Glucanase, Other Specialty Enzymes
What Current And Upcoming Trends Are Shaping The Enzymes Market?
Leading companies in the enzyme market are developing innovative products like Lamzede to better serve patients. Lamzede (velmanase alfa) is a medication utilized for the treatment of alpha-mannosidosis, a rare genetic condition caused by insufficient activity of the lysosomal alpha-galactosidase-A enzyme. For example, in May 2023, Chiesi Global Rare Diseases, a US-based pharmaceutical manufacturing company, obtained FDA approval for Lamzede (velmanase alfa) for the treatment of non-neurological symptoms in patients with mild-to-moderate alpha-mannosidosis. Lamzede is a recombinant form of human alpha-mannosidase, developed in mammalian Chinese hamster ovary (CHO) cells through recombinant DNA technology. It marks the first enzyme replacement therapy approved in the U.S. for managing the non-central nervous system manifestations of alpha-mannosidosis.
Who Are The Primary Market Leaders In The Enzymes Market?
Major companies operating in the enzymes market include Novozymes A/S, DuPont Industrial Biosciences, BASF SE, Koninklijke DSM N.V., Chr. Hansen Holding A/S, Roche Holding AG, Advanced Enzyme Technologies Ltd., AB Enzymes GmbH, Codexis Inc., Dyadic International Inc., Amano Enzyme Inc., Adisseo France SAS, Biocatalysts Ltd., Amano Enzyme Inc., Enzyme Development Corporation, Creative Enzymes, Hayashibara Co. Ltd., Thermo Fisher Scientific Inc., Associated British Foods Plc, Lonza Group AG, Novus International Inc., Epygen Biotech, DSM Nutritional Products AG, Soufflet Biotechnologies SAS, Beijing Leili Marine Bioindustry Inc., Jiangsu Boli Bioproducts Co. Ltd.
Download The Full Report Here:
https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report
Which Regional Markets Are Emerging As Key Centers For The Enzymes Market?
North America was the largest region in the enzymes market in 2024. The regions covered in the enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=3425&type=smp
Browse Through More Reports Similar to the Global Enzymes Market 2025, By The Business Research Company
Digestive Enzyme Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/digestive-enzyme-global-market-report
Specialty Enzyme Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/specialty-enzyme-global-market-report
Animal Growth Promoters And Performance Enhancers Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
